Brief: Aurinia Receives Exemptive Relief From Canadian Securities Regulators For Share Repurchase Program
29/02/2024 13:38
Feb 29 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O :
* AURINIA RECEIVES EXEMPTIVE RELIEF FROM CANADIAN SECURITIES
REGULATORS FOR SHARE REPURCHASE PROGRAM
* AURINIA RECEIVES EXEMPTIVE RELIEF FROM CANADIAN SECURITIES
REGULATORS FOR SHARE REPURCHASE PROGRAM
* AURINIA PHARMACEUTICALS INC - TO PURCHASE UP TO 15% OF
ISSUED,
OUTSTANDING SHARES IN ANY 12-MONTH PERIOD FOR UP TO 36 MONTHS
Source text for Eikon: ID:nBw3WmRLYa
Further company coverage: AUPH.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aurinia Pharmaceuticals
See all newsBrief: Aurinia Settles Patent Litigation With Teva
Canada's Aurinia Q2 revenue rises on LUPKYNIS sales
Brief: Aurinia Pharmaceuticals Q2 Pretax Profit USD 48.786 Million
Aurinia Pharmaceuticals Inc expected to post earnings of 24 cents a share - Earnings Preview
Brief: Lupkynis Associated With A Statistically Significant 53% Reduction In Risk Of Renal-Related Event Or Death